The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum

Neuropharmacology

Volumn 55, Issue 5, 2008, Pages 755-762

  Bosse, Kelly E ^a   Jutkiewicz, Emily M ^a   Gnegy, Margaret E ^a   Traynor, John R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Amphetamine; Delta opioid; Dopamine; Naltrindole; SNC80; Striatum

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; AMPHETAMINE; COCAINE; DELTA OPIATE RECEPTOR AGONIST; DOPAMINE; DOPAMINE TRANSPORTER; DRUG VEHICLE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NALTRINDOLE; OXYMORPHINDOLE; PSYCHOSTIMULANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; DOSE TIME EFFECT RELATION; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BENZAMIDES; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERAZINES; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SUBCELLULAR FRACTIONS; TIME FACTORS; TRITIUM;

EID: 51249112534     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.06.017     Document Type: Article

References (46)

1. Billet F., Dourmap N., and Costentin J. Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of delta-opioid receptors. Eur. J. Neurosci. 20 (2004) 2629-2638
2. Bosse K.E., Jutkiewicz E.M., Gnegy M.E., and Traynor J.R. The Selective Delta Opioid Agonist, SNC80, Increases Amphetamine-mediated Release of Dopamine (2006), Experimental Biology - ASPET, San Francisco, CA
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Broom D.C., Jutkiewicz E.M., Folk J.E., Traynor J.R., Rice K.C., and Woods J.H. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 26 (2002) 744-755
5. *)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N ,N-diethylbenzamide (SNC80) and related novel nonpeptide delta opioid receptor ligands. J. Med. Chem. 40 (1997) 695-704
6. Carboni E., Imperato A., Perezzani L., and Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentration preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28 (1989) 653-661
7. Das D., Rogers J., and Michael-Titus A.T. Comparative study of the effects of mu, delta, and kappa opioid agonists on 3H-dopamine uptake in rat striatum and nucleus accumbens. Neuropharmacology 33 (1994) 221-226
8. Devine D.P., and Wise R.A. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14 (1994) 1978-1984
9. Devine D.P., Leone P., Pocock D., and Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266 (1993) 1236-1246
10. Dourmap N., and Costentin J. Involvement of glutamate receptor in the striatal enkephalin-induced dopamine release. Eur. J. Pharmacol. 253 (1994) R9-R11
11. Duvauchelle C.L., Fleming S.M., and Kornetsky C. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward. Eur. J. Pharmacol. 316 (1996) 137-143
12. Gnegy M.E. The effect of phosphorylation on amphetamine-mediated outward transport. Eur. J. Pharmacol. 479 (2003) 83-91
13. Heffner T.G., Hartman J.A., and Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13 (1980) 453-456
14. Hoebel B.G., Monaco A.P., Hernandez L., Aulisi E.F., Stanley B.G., and Lenard L. Self-injection of amphetamine directly into the brain. Psychopharmacology (Berl.) 81 (1983) 158-163
15. Jones D.N.C., and Holtzman S.G. Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors. J. Pharmacol. Exp. Ther. 227 (1992) 229-237
16. Jutkiewicz E.M., Chang K.J., Rice K.C., and Woods J.H. Characterization of a Novel Nonpeptidic Delta-opioid Agonist Analog DPI-287 (2005), Experimental Biology - ASPET, San Diego, CA
17. 35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 312 (2005) 1314-1320
18. Jutkiewicz E.M., Rice K.C., and Woods J.H. The delta-opioid receptor agonist SNC80 synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists in rats. J. Pharmacol. Exp. Ther. 324 (2008) 714-724
19. Kantor L., and Gnegy M.E. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284 (1998) 592-598
20. *)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide] and endogenous enkephalins. J. Pharmacol. Exp. Ther. 310 (2004) 666-677
21. Liang N.Y., and Rutledge C.O. Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. Biochem. Pharmacol. 31 (1982) 983-992
22. Longoni R., Cadoni C., Mulas A., Di Chiara G., and Spina L. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. Behav. Pharmacol. 9 (1998) 9-14
23. Lubetzki C., Chesselet M.F., and Glowinski J. Modulation of dopamine release in rat striatal slices by delta opiate agonist. J. Pharmacol. Exp. Ther. 222 (1982) 435-440
24. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18 (1995) 22-29
25. Manzanares J., Durham R.A., Lookingland K.J., and Moore K.E. Delta-opioid receptor-mediated regulation of central dopaminergic neurons in the rat. Eur. J. Pharmacol. 249 (1993) 107-112
26. Menkens K., Bilsky E.J., Wild K.D., Portoghese P.S., Reid L.D., and Porreca F. Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole. Eur. J. Pharmacol. 219 (1992) 345-346
27. Meyer M.E., and Meyer M.E. Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities. Pharmacol. Biochem. Behav. 45 (1993) 315-320
28. Mori T., Ito S., Kita T., Narita M., Suzuki T., and Sawaguchi T. Effects of mu-, delta-, and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice. Eur. J. Pharmacol. 532 (2006) 81-87
29. Mulder A.H., Wardeh G., Hogenboom F., and Frankhuyzen A.L. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308 (1984) 278-280
30. Negus S.S., Gatch M.B., Mello N.K., Zhang X., and Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J. Pharmacol. Exp. Ther. 286 (1998) 362-375
31. Pentney R.J., and Gratton A. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience 45 (1991) 95-102
32. Petit F., Hamon M., Fournie-Zaluski M.C., Roques B.P., and Glowinski J. Further evidence for a role of delta-opioid receptors in the presynaptic regulation of newly synthesized dopamine release. Eur. J. Pharmacol. 126 (1986) 1-9
33. Rowlett J.K., and Spealman R.D. Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of mu and delta opioid receptors. Psychopharmacology (Berl.) 140 (1998) 217-224
34. Schad C.A., Justice Jr. J.B., and Holtzman S.G. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J. Neurochem. 67 (1996) 2292-2299
35. Scherrer G., Befort K., Contet C., Becker J., Matifas A., and Kieffer B.L. The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur. J. Neurosci. 19 (2004) 2239-2248
36. Seiden L.S., and Sabol K.E. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 32 (1993) 639-677
37. Shippenberg T.S., Bals-Kubik R., and Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res. 436 (1987) 234-239
38. Spanagel R., Herz A., and Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55 (1990) 1734-1740
39. Spina L., Longoni R., Mulas A., Chang K.L., and Di Chiara G. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC80: 1. Locomotion, rearing, and stereotypies in intact rats. Behav. Pharmacol. 9 (1998) 1-8
40. Suzuki T., Tsuji M., Mori T., Ikeda H., Misawa M., and Nagase H. The effects of dopamine D1 and D2 receptor antagonists on the rewarding effects of delta 1 and delta 2 opioid receptor agonists in mice. Psychopharmacology (Berl.) 124 (1996) 211-218
41. Svingos A.L., Clarke C.L., and Pickel V.M. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implication for opiate and psychostimulant cross-sensitization. Synapse 34 (1999) 1-10
42. Tang T., Kiang J.G., and Cox B.M. Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells. J. Pharmacol. Exp. Ther. 270 (1994) 40-46
43. Trovero F., Herve D., Desban M., Glowinski J., and Tassin J.P. Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat. Neuroscience 39 (1990) 313-321
44. 5]enkephalin, in the rat. Eur. J. Pharmacol. 231 (1993) 143-144
45. Waddell A.B., and Holtzman S.G. Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists. Behav. Pharmacol. 9 (1998) 397-407
46. Wang J.K. Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes. J. Neurochem. 57 (1991) 819-822